Back

New interesting targets for heart failure therapy in the natriuretic peptide clearance system- could type c natriuretic peptide receptor be as promissing as neprilysin?

21 May 2016 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science: Biomarkers Natriuretic peptides HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Katarzyna Kodziszewska

Medical University of Warsaw, Warsaw (Poland)

13 More presentations in this session

Presentation thumbnail
Doctor M. Cabiati (Pisa, IT)
Abstract
Presentation thumbnail
Miss F. Dei Zotti (Brussels, BE)
Abstract
Presentation thumbnail
Ms M. Vausort (Luxembourg, LU)
Abstract
Presentation thumbnail
Doctor A. Salgado Somoza (Luxembourg, LU)
Abstract
Presentation thumbnail
Doctor F. Azibani (Rondebosch, ZA)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Basic Science: Biomarkers

The Event

Event poster

HEART FAILURE 2016

21 May 2016 08:30 CET
You may be interested in
thumbnail
Webinar
Natriuretic peptides: role for risk prediction and treatment efficacy
7 October 2021
thumbnail
Congress Presentation
Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac
21 May 2023
thumbnail
Congress Presentation
Altered arginin-vasopressin (AVP)/apelin system balance in congestive heart failure patients under diuretic resistance: results from a pilot study
31 August 2025
thumbnail
Congress Presentation
Dipeptidyl peptidase-3, a marker of the antagonist pathway of the renin-angiotensin-aldosterone system in patients with heart failure
30 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources